Fentanyl | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fentanyl
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Veranova Fentanyl

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Fentanyl

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 12 USDMF, 11 CEP/COS, 3 JDMF, 1 EU WC, 4 KDMF, 13 NDC API, 10 Listed Suppliers, $ API Reference Price

24 API Suppliers
12 USDMF
11 CEP/COS
3 JDMF
1 EU WC
4 KDMF
13 NDC API
10 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

496 FDF Dossiers, 71 FDA Orange Book, 392 Europe, 5 Canada, 2 South Africa, 26 Listed Dossiers

496 FDF Dossiers
71 FDA Orange Book
392 Europe
5 Canada
2 South Africa
26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 100MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 12.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 25MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 37.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 50MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 75MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM, EXTENDED RELEASE;TRANSDERMAL - 100MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FILM, EXTENDED RELEASE;TRANSDERMAL - 12.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FILM, EXTENDED RELEASE;TRANSDERMAL - 25MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FILM, EXTENDED RELEASE;TRANSDERMAL - 37.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FILM, EXTENDED RELEASE;TRANSDERMAL - 50MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FILM, EXTENDED RELEASE;TRANSDERMAL - 75MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 2 Boai NKY Pharmaceuticals Ltd, 1 Nanjing Well Pharmaceutical, 1 Actylis, 1 Alcedo Pharmachem, 5 BASF, 1 Huzhou Sunflower Pharmaceutical, 1 Microlex e.U, 1 Novo Excipients

1 SPI Pharma
3 DKSH
2 Boai NKY Pharmaceuticals Ltd
1 Nanjing Well Pharmaceutical
1 Actylis
1 Alcedo Pharmachem
5 BASF
1 Huzhou Sunflower Pharmaceutical
1 Microlex e.U
1 Novo Excipients

EXCIPIENTS BY APPLICATIONS

8 Topical, 7 Fillers, Diluents & Binders, 5 Direct Compression, 4 Film Formers & Plasticizers, 3 Rheology Modifiers, 3 Thickeners and Stabilizers, 2 Granulation, 2 Solubilizers, 1 Controlled & Modified Release, 1 Taste Masking, 1 Coating Systems & Additives

8 Topical
7 Fillers, Diluents & Binders
5 Direct Compression
4 Film Formers & Plasticizers
3 Rheology Modifiers
3 Thickeners and Stabilizers
2 Granulation
2 Solubilizers
1 Controlled & Modified Release
1 Taste Masking
1 Coating Systems & Additives

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 193 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
193 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 370 Finished Drug Prices, 21 Annual Reports

3 US Medicaid Prescriptions
370 Finished Drug Prices
21 Annual Reports

MARKET PLACE

5 APIs, 21 FDF Dossiers

5 APIs
21 FDF Dossiers

PATENTS & EXCLUSIVITIES

68 US Patents, 5 Health Canada Patents

68 US Patents
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 6 USP, 11 Others

2 EDQM
6 USP
11 Others

$ API Ref.Price (USD/KG) : 45,257 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Valeant Canada LP

filter Patent Reset all filters

5 All

01 52658585

filter Product Reset all filters

5 All

01 5Fentanyl

filter Dosage Reset all filters

5 All

01 5Buccal Soluble Film

filter Exp Date Reset all filters

5 All

01 52027-07-23

Product Main Page

01

Valeant Canada LP

Fentanyl

PharmScience R&D

Not Confirmed

Valeant Canada LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

Date Granted : 2011-03-01

Brand Name : ONSOLIS

Patent Number : 2658585

Filing Date : 2007-07-23

Strength per Unit : 600 mcg

Dosage Form : Buccal Soluble Film

Human Or VET : Human

Route of Administration : Transmucosal

Patent Expiration Date : 2027-07-23

Date Granted : 2011-03-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Valeant Canada LP

Fentanyl

PharmScience R&D

Not Confirmed

Valeant Canada LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

Date Granted : 2011-03-01

Brand Name : ONSOLIS

Patent Number : 2658585

Filing Date : 2007-07-23

Strength per Unit : 800 mcg

Dosage Form : Buccal Soluble Film

Human Or VET : Human

Route of Administration : Transmucosal

Patent Expiration Date : 2027-07-23

Date Granted : 2011-03-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Valeant Canada LP

Fentanyl

PharmScience R&D

Not Confirmed

Valeant Canada LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

Date Granted : 2011-03-01

Brand Name : ONSOLIS

Patent Number : 2658585

Filing Date : 2007-07-23

Strength per Unit : 1200 mcg

Dosage Form : Buccal Soluble Film

Human Or VET : Human

Route of Administration : Transmucosal

Patent Expiration Date : 2027-07-23

Date Granted : 2011-03-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Valeant Canada LP

Fentanyl

PharmScience R&D

Not Confirmed

Valeant Canada LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

Date Granted : 2011-03-01

Brand Name : ONSOLIS

Patent Number : 2658585

Filing Date : 2007-07-23

Strength per Unit : 200 mcg

Dosage Form : Buccal Soluble Film

Human Or VET : Human

Route of Administration : Transmucosal

Patent Expiration Date : 2027-07-23

Date Granted : 2011-03-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Valeant Canada LP

Fentanyl

PharmScience R&D

Not Confirmed

Valeant Canada LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

Date Granted : 2011-03-01

Brand Name : ONSOLIS

Patent Number : 2658585

Filing Date : 2007-07-23

Strength per Unit : 400 mcg

Dosage Form : Buccal Soluble Film

Human Or VET : Human

Route of Administration : Transmucosal

Patent Expiration Date : 2027-07-23

Date Granted : 2011-03-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!